Bayer Called On To Address Global Claims After US Settlement In Essure Case

August 30, 2020

Thousands of claims have now been settled in the USA surrounding the controversial Essure implant, but we are still fighting for justice for thousands of other victims.

While the $1.6 billion settlement decision in the US is welcomed, our firm is still helping the many UK victims who are awaiting justice after years of suffering with chronic pelvic or lower abdominal pain, abnormal uterine bleeding and allergic or autoimmune complications.

Harris Pogust, Chairman, called Essure ‘one of the most dangerous medical devices that has been put on the market in recent memory’ and asked for Bayer to be held accountable.

“Bayer was aware of the risks of severe complications but intentionally failed to inform the public, he said.

“When the truth came out, Bayer took Essure off of the market but that was too late for the hundreds of thousands of women affected. Now, Bayer has decided to compensate women in the United States for its incomprehensible conduct. Do women in the UK not feel the same pain? Have they not endured the same suffering?

“It’s time for Bayer to be held to account and to compensate the thousands of women in the UK who have suffered avoidable pain and suffering.”

What is Essure?

It is estimated that 100,000 women in the UK have been fitted with an Essure implant, a device made available by the NHS and administered in GP surgeries from 2002 to 2017.

It was offered as a non-surgical alternative to traditional sterilisation methods, but many women who had it fitted have been left in crippling pain and facing limited treatment options.

Many women have had to endure multiple surgeries to remove Essure, a complex procedure that often calls for a total hysterectomy.

If you have been affected by Bayer’s negligence, please contact us to join us in our fight for justice and receive the compensation you deserve.

Find out more about the ongoing Essure case. 

More Press

high court ruling
A Significant Ruling From The High Court 
We’re pleased to report a significant ruling from the High Court: the decisions which approve diesel vehicles or updates to them made by the German...
Read More
transvaginal-mesh-positive-decision
Pogust Goodhead resolve claims against three manufacturers of Transvaginal Mesh
Pogust Goodhead are pleased to announce that we have now resolved claims against three manufacturers of transvaginal mesh.
Read More
Insights (768 × 507px) (3)
Pogust Goodhead shortlisted for the FT Innovative Lawyers Awards
We are delighted to announce that we have been shortlisted for the FT Innovative Lawyers Awards.
Read More